Novomedicon ApS: Financial statements 2022
CVR: 38818791
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
Novomedicon ApS (CVR 38818791) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -6,982 and a net result of DKK -7,312 compared with DKK -522 the year before. Equity in the 2022 report amounted to DKK 27,523. The solvency ratio was 3.7%.
- Gross Profit
- DKK -6,982
- Profit/Loss
- DKK -7,312
- Equity
- DKK 27,523
- Total Assets
- DKK 743,822
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | -7K | -7K | 28K | - |
| 2021 | - | - | -522 | 35K | - |
| 2020 | - | 0 | -5K | -5K | 1 |
| 2019 | - | 0 | 0 | 100 | 1 |
| 2018 | 0 | 0 | 0 | 0 | - |
Official annual report
Keep an eye on Novomedicon ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
Novomedicon ApS has published its annual report for 2021. The net result was DKK -522.
About Novomedicon ApS
Novomedicon ApS is a Danish company of the type Anpartsselskab based in Hellerup, founded in 2017. The company is registered under the industry Fremstilling af medicinske og dentale instrumenter samt udstyr hertil. The company was previously named Novomedicon IVS. The management consists of Jens Dahlgaard Hove. The company is owned by Jens Dahlgaard Hove. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -7,598 and a net result of DKK -7,598 compared with DKK -7,538 the year before. Equity in the 2025 report amounted to DKK 5,125.
